Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 02, 2015 3:43 PM ET

Pharmaceuticals

Company Overview of Pfizer Inc.

Executive Profile

Stephen W. Sanger

Independent Director, Chairman of Corporate Governance Committee, Member of Executive Committee, Member of Audit Committee and Member of Science & Technology Committee, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 7 different industries.

See Board Relationships
69$345,000

Background

Mr. Stephen W. Sanger, also known as Steve, has been Director of Wells Fargo & Company since July 22, 2003 and has been its Lead Director since January 1, 2012. He has been an Independent Director of Pfizer Inc. since February 3, 2009 and Target Corp., since 1996 until March 13, 2013. He serves as a Director of General Mills Operations Inc. He serves as a Member of the Board of Advisors at the Retail Food Industry Center. He served as the President of Yoplait USA and ...

Corporate Headquarters

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships

2003-Present
Lead Director, Chairman of Governance & Nominating Committee, Member of Human Resources Committee and Member of Risk Committee
2009-Present
Independent Director, Chairman of Corporate Governance Committee, Member of Executive Committee, Member of Audit Committee and Member of Science & Technology Committee

Education

MBA 1970
University of Michigan
Bachelor's Degree 1968
DePauw University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$182,500
Total Calculated Compensation$345,000
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Paul Bulcke B.E.Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee
Nestlé S.A.
$5.7M
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$6.4M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pfizer Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.